164.43USD+3.23%Mkt Cap: 11.39B $P/E: 38.421d ago
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap11.39B $
Enterprise Value11.57B $
Revenue (TTM)2.90B $
Gross Profit1.94B $
Net Income (TTM)247.10M $
Revenue/Share41.28 USD
Last Price164.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)38.42
P/E (Forward)20.42
PEG1.40
EV/EBITDA19.21
EV/Revenue3.99
P/S3.93
P/B8.74
EPS (TTM)4.28
EPS (Forward)8.05
52W Range
138.7912% of range354.88
52W High354.88 USD
52W Low138.79 USD
Profitability
Gross Margin71.63%
Oper. Margin16.03%
EBITDA Margin20.75%
Profit Margin9.12%
ROE16.31%
ROA7.75%
Growth
Revenue Growth33.90%
Earnings Growth159.00%
Cash Flow & Leverage
Operating CF569.30M $
CapEx (TTM)219.40M $
FCF Margin8.73%
FCF Yield2.22%
Net Debt533.60M $
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.63
Current Ratio2.49
Quick Ratio1.49
Book Value/Sh18.81 USD
Cash/Share6.936 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)238.22 USD
Upside (mean)+44.9%
Target Range172.00 USD – 360.00 USD
$172.00+44.9% to mean$360.00
# Analysts23
Ownership
Shares Out.69.26M
Float68.98M
Insiders0.33%
Institutions104.99%
Short Interest
Short Ratio3.0d
Short % Float7.91%
Short % Out.7.01%
Shares Short4.85M
Short (prev mo.)4.23M
Technical
SMA 50153.23 (+7.3%)
SMA 200241.05 (-31.8%)
Beta1.11
S&P 52W Chg20.25%
Avg Vol (30d)1.42M
Avg Vol (10d)1.30M
Technical Indicators
RSI (14)58.0
MACD2.2010
MACD Signal1.1448
MACD Hist.+1.0562
BB Upper170.38 USD
BB Middle155.04 USD
BB Lower139.70 USD
BB Width19.79%
ATR (14)6.885 USD
Vol Ratio (20d)1.01x